Latest Ratios: P/E Ratio 30.0x · EV/EBITDA 12.3x · ROE 4.6%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $10.9B | $14.0B | $21.0B | $15.5B | $13.6B | $20.8B | $15.8B | $14.6B | $12.8B | $11.9B | $8.6B |
| Enterprise Value | $13.6B | $16.7B | $23.5B | $18.0B | $16.2B | $22.2B | $17.8B | $16.3B | $14.8B | $13.0B | $9.9B |
| P/E Ratio → | 29.98 | 37.39 | 53.41 | 52.66 | 35.23 | 1.76 | 16.58 | 7.81 | 22.98 | 7.99 | 7.87 |
| P/S Ratio | 2.67 | 3.42 | 5.39 | 4.32 | 4.11 | 7.11 | 6.50 | 5.49 | 5.07 | 5.57 | 4.39 |
| P/B Ratio | 1.36 | 1.70 | 2.60 | 2.06 | 1.89 | 2.99 | 4.13 | 4.01 | 3.88 | 3.75 | 3.20 |
| P/FCF | 25.21 | 32.24 | 72.81 | 72.21 | 30.17 | 39.65 | 89.72 | 34.59 | 27.01 | 25.55 | 24.16 |
| P/OCF | 13.74 | 17.56 | 29.58 | 25.56 | 19.62 | 28.14 | 32.49 | 20.42 | 19.19 | 20.07 | 16.93 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.07 | 6.02 | 5.00 | 4.90 | 7.59 | 7.30 | 6.14 | 5.84 | 6.08 | 5.01 |
| EV / EBITDA | 12.31 | 15.06 | 21.70 | 19.95 | 18.99 | 27.20 | 29.65 | 19.70 | 21.80 | 21.05 | 18.87 |
| EV / EBIT | 19.93 | 26.42 | 33.67 | 34.69 | 30.44 | 43.08 | 58.54 | 29.89 | 35.66 | 30.42 | 30.64 |
| EV / FCF | — | 38.40 | 81.41 | 83.60 | 36.00 | 42.29 | 100.77 | 38.71 | 31.10 | 27.87 | 27.62 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.7% | 60.7% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% | 66.2% | 64.4% | 63.9% | 59.6% |
| Operating Margin | 16.7% | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% | 20.1% | 16.5% |
| Net Profit Margin | 9.2% | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.6% | 4.6% | 5.0% | 4.0% | 5.5% | 54.7% | 6.4% | 13.5% | 4.3% | 12.7% | 10.2% |
| ROA | 3.0% | 3.0% | 3.3% | 2.5% | 3.7% | 36.0% | 3.7% | 7.5% | 2.6% | 8.0% | 6.1% |
| ROIC | 4.8% | 4.8% | 5.1% | 4.0% | 4.2% | 5.4% | 4.2% | 7.7% | 6.4% | 7.9% | 6.1% |
| ROCE | 6.1% | 6.1% | 6.4% | 5.1% | 5.3% | 6.9% | 5.7% | 10.2% | 8.0% | 10.2% | 8.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.34 | 0.34 | 0.32 | 0.34 | 0.39 | 0.21 | 0.54 | 0.50 | 0.61 | 0.37 | 0.49 |
| Debt / EBITDA | 2.52 | 2.52 | 2.39 | 2.85 | 3.24 | 1.82 | 3.45 | 2.21 | 2.98 | 1.90 | 2.55 |
| Net Debt / Equity | — | 0.32 | 0.31 | 0.32 | 0.37 | 0.20 | 0.51 | 0.48 | 0.59 | 0.34 | 0.46 |
| Net Debt / EBITDA | 2.42 | 2.42 | 2.29 | 2.72 | 3.08 | 1.70 | 3.25 | 2.10 | 2.87 | 1.76 | 2.36 |
| Debt / FCF | — | 6.16 | 8.59 | 11.39 | 5.83 | 2.64 | 11.05 | 4.13 | 4.09 | 2.32 | 3.45 |
| Interest Coverage | 6.30 | 6.30 | 6.09 | 4.92 | 9.29 | 22.28 | 8.24 | 8.02 | 5.01 | 12.80 | 12.29 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.89 | 1.89 | 1.91 | 1.76 | 1.20 | 2.00 | 1.27 | 1.05 | 2.03 | 2.41 | 1.74 |
| Quick Ratio | 1.13 | 1.13 | 1.12 | 1.00 | 0.71 | 1.20 | 0.70 | 0.59 | 1.16 | 1.26 | 0.96 |
| Cash Ratio | 0.10 | 0.10 | 0.11 | 0.12 | 0.11 | 0.13 | 0.12 | 0.08 | 0.14 | 0.22 | 0.19 |
| Asset Turnover | — | 0.33 | 0.32 | 0.31 | 0.29 | 0.30 | 0.36 | 0.42 | 0.41 | 0.44 | 0.44 |
| Inventory Turnover | 1.90 | 1.90 | 1.62 | 1.68 | 1.86 | 1.65 | 1.57 | 1.77 | 1.92 | 1.70 | 1.90 |
| Days Sales Outstanding | — | 73.94 | 67.18 | 61.93 | 61.54 | 64.36 | 65.38 | 59.88 | 54.00 | 54.02 | 54.08 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Payout Ratio | — | — | — | 1.0% | 0.8% | 0.1% | 1.3% | 0.6% | 2.1% | 0.8% | 1.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.3% | 2.7% | 1.9% | 1.9% | 2.8% | 56.7% | 6.0% | 12.8% | 4.4% | 12.5% | 12.7% |
| FCF Yield | 4.0% | 3.1% | 1.4% | 1.4% | 3.3% | 2.5% | 1.1% | 2.9% | 3.7% | 3.9% | 4.1% |
| Buyback Yield | 2.7% | 2.1% | 0.0% | 0.0% | 0.6% | 0.1% | 0.3% | 1.1% | 0.0% | 0.5% | 0.0% |
| Total Shareholder Yield | 2.7% | 2.1% | 0.0% | 0.0% | 0.6% | 0.1% | 0.3% | 1.1% | 0.0% | 0.5% | 0.0% |
| Shares Outstanding | — | $200M | $200M | $199M | $199M | $199M | $198M | $200M | $199M | $198M | $196M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying COO stock.
The Cooper Companies, Inc.'s current P/E ratio is 30.0x. The historical average is 11.8x. This places it at the 86th percentile of its historical range.
The Cooper Companies, Inc.'s current EV/EBITDA is 12.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.8x.
The Cooper Companies, Inc.'s return on equity (ROE) is 4.6%. The historical average is 21.2%.
Based on historical data, The Cooper Companies, Inc. is trading at a P/E of 30.0x. This is at the 86th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
The Cooper Companies, Inc. has 60.7% gross margin and 16.7% operating margin. Operating margin between 10-20% is typical for established companies.
The Cooper Companies, Inc.'s Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
Volatile Margins & Earnings Quality
Metrics are mathematically derived from official filings.
Valuation Discounted for Earnings Inflection
As reported in COO's valuation data, the forward P/E of 12.01 compared to the trailing P/E of 29.20 suggests the market anticipates a significant earnings recovery, yet this optimism appears at odds with the company's recent decelerating top-line growth.
The substantial compression in forward multiples indicates an expectation that non-recurring charges, like the 2026Q2 SG&A surge, are temporary and that underlying earnings power will re-emerge. However, the forward EV/EBITDA of 7.84 remains below peers like Hologic, implying that investors may still be pricing in execution risk from integration and competitive pressures in the vision care segment.
Margin Volatility Amid Structural Strengths
Based on COO's reported figures, gross margin averaged 65.0% over ten quarters but plunged to 56.4% in 2025Q4, indicating vulnerability to input costs and integration disruptions that obscure the business's premium pricing power.
The significant swing in operating margin, from -2.9% in 2026Q2 to 20.9% in 2026Q3, suggests that non-recurring items heavily distort the quarterly profile, making the 10-quarter operating margin of approximately 17% a better indicator of sustainable earning power. This volatility implies that cost control and mix optimization, rather than volume growth, are the primary drivers of near-term margin expansion.
Low Leverage Provides Buffer for Integration
According to recent balance sheet data, COO's debt-to-equity ratio held steady at 0.31 in 2026Q3 with interest coverage at 8.27, indicating that the company maintains ample financial flexibility to absorb integration costs and pursue strategic acquisitions.
The stable leverage profile contrasts with the volatile earnings trajectory, providing a cushion that should prevent refinancing risk even if operational disruptions persist. However, the reliance on acquisition-driven growth means that future increases in debt could strain this flexibility, requiring careful monitoring of return on invested capital.
Tightening Liquidity Warrants Scrutiny
As reported in the ratio data, COO's current ratio compressed from 1.95 in 2024Q2 to 1.22 in 2026Q3, a trend that appears concerning given the consistently high cash conversion cycle exceeding 200 days over the period.
The decline in the current ratio, coupled with a quick ratio below 1.0 in recent quarters, suggests that working capital management has become less efficient, potentially tying up cash in inventory and receivables. This tightening liquidity profile may limit operational agility during periods of stress, despite the low overall debt levels.
Mixed Positioning Against Specialized Peers
In peer comparison, COO's forward P/E of 12.01 trades at a discount to Hologic's 30.53, as per peer data, yet its ROIC of 1.6% lags significantly behind Hologic's 9.4%, highlighting gaps in capital efficiency despite a stronger balance sheet.
While COO's valuation multiples appear attractive relative to higher-growth peers like Edwards Lifesciences, the lower return metrics suggest that acquisition-driven expansion has not yet translated into superior profitability compared to organically focused competitors. This divergence may indicate that the market is pricing in the risk that integration challenges could erode potential synergies.
Net Margin as a Misleading Metric
The most commonly misapplied ratio for COO is net margin, which swung from -7.2% in 2026Q2 to 40.6% in 2026Q3 due to non-recurring items, obscuring core operational profitability that should instead be assessed via adjusted operating margins.
Net margin volatility, driven by acquisition accounting and tax adjustments, frequently misleads investors into overreacting to quarterly swings that do not reflect underlying business performance. A more reliable alternative is the operating margin, which, despite its own volatility, better captures the earning power of the core manufacturing and sales operations by excluding these distortions.